Loading…

ORIGINAL ARTICLE: Differential Role of Corticotrophin-Releasing Factor Receptor Types 1 and 2 in Stress-Induced Suppression of Pulsatile Luteinising Hormone Secretion in the Female Rat

Corticotrophin-releasing factor (CRF) plays a pivotal role in stress-induced suppression of the gonadotrophin-releasing hormone pulse generator. We have previously shown that type 2 CRF receptors (CRF sub(2)) mediate restraint stress-induced suppression of luteinising hormone (LH) pulses in the rat....

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroendocrinology 2006-08, Vol.18 (8), p.602-610
Main Authors: Li, X F, Bowe, JE, Kinsey-Jones, J S, Brain, S D, Lightman, S L, O'Byrne, K T
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Corticotrophin-releasing factor (CRF) plays a pivotal role in stress-induced suppression of the gonadotrophin-releasing hormone pulse generator. We have previously shown that type 2 CRF receptors (CRF sub(2)) mediate restraint stress-induced suppression of luteinising hormone (LH) pulses in the rat. The present study aimed: (i) to determine whether type 1 CRF receptors (CRF sub(1)) are also involved in this response to restraint and (ii) to investigate the differential involvement of CRF sub(1) and CRF sub(2) in the suppression of LH pulses in response to the metabolic perturbation of insulin-induced hypoglycemia and the innate immunological challenge of lipopolysaccharide (LPS). Ovariectomised rats with oestrogen replacement were implanted with intracerebroventricular (i.c.v.) and intravenous (i.v.) cannulae. Blood samples (25 mu l) were collected every 5 min for 5 h for LH measurement. After 2 h of controlled blood sampling, rats were either exposed to restraint (1 h) or injected intravenously with insulin (0.25 IU-kg) or LPS (5 mu g-kg). All three stressors suppressed LH pulses. The CRF sub(1) antagonist SSR125543Q (11.5 mu mol-rat i.v., 30 min before stressor) blocked the inhibitory response to restraint, but not hypoglycaemia or LPS stress. In addition to its effect on restraint, the CRF sub(2) antagonist astressin sub(2)-B (28 nmol-rat i.c.v., 10 min before insulin or LPS) blocked hypoglycaemia or LPS stress-induced suppression of LH pulses. These results suggest that hypoglycaemia and LPS stress-induced LH suppression involves activation of CRF sub(2) while restraint stress-induced inhibition of LH pulses involves both CRF sub(1) and CRF sub(2).
ISSN:0953-8194
1365-2826
DOI:10.1111/j.1365-2826.2006.01450.x